BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6182740)

  • 1. Differentiation of amyloid fibril proteins in tissue sections. Two simple and reliable histological methods applied to fifty-one cases of systemic amyloidosis.
    Fujihara S
    Acta Pathol Jpn; 1982 Sep; 32(5):771-82. PubMed ID: 6182740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of monoclonal antibody against amyloid fibril protein and its immunohistochemical application.
    Kurashima C; Hirokawa K
    Appl Pathol; 1985; 3(1-2):39-54. PubMed ID: 3915946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method to classify amyloid fibril proteins.
    Kitamoto T; Tateishi J; Hikita K; Nagara H; Takeshita I
    Acta Neuropathol; 1985; 67(3-4):272-8. PubMed ID: 4050342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections.
    Looi LM
    Pathology; 1986 Jan; 18(1):137-40. PubMed ID: 2425332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
    Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
    Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
    van Rijswijk MH; van Heusden CW
    Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
    Bély M; Apáthy A
    Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis.
    Hoshii Y; Takahashi M; Ishihara T; Uchino F
    Pathol Int; 1994 May; 44(5):352-8. PubMed ID: 8044304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of spontaneous amyloidosis of Syrian hamsters using the potassium permanganate method.
    Mezza LE; Quimby FW; Durham SK; Lewis RM
    Lab Anim Sci; 1984 Aug; 34(4):376-80. PubMed ID: 6482376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
    Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
    Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of different amyloid fibril proteins in tissue sections.
    Cornwell GG; Husby G; Westermark P; Natvig JB; Michaelsen TE; Skogen B
    Scand J Immunol; 1977; 6(11):1071-80. PubMed ID: 413186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathological diagnosis of amyloidosis].
    Hoshii Y
    Rinsho Byori; 2006 May; 54(5):513-8. PubMed ID: 16789423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
    Sipe JD; Benson MD; Buxbaum JN; Ikeda SI; Merlini G; Saraiva MJ; Westermark P
    Amyloid; 2016 Dec; 23(4):209-213. PubMed ID: 27884064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.
    Wright JR; Calkins E; Humphrey RL
    Lab Invest; 1977 Mar; 36(3):274-81. PubMed ID: 839739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic amyloidosis: morphologic differences between systemic AL and AA types.
    Buck FS; Koss MN
    Hum Pathol; 1991 Sep; 22(9):904-7. PubMed ID: 1916751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia associated with AA amyloidosis.
    Gardyn J; Schwartz A; Gal R; Lewinski U; Kristt D; Cohen AM
    Int J Hematol; 2001 Jul; 74(1):76-8. PubMed ID: 11530809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis.
    Looi LM; Sumithran E
    Hum Pathol; 1988 Jun; 19(6):732-5. PubMed ID: 2454214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cell dyscrasia in 105 Japanese patients with systemic amyloidosis.
    Isobe T; Tomita M; Matsumoto J; Fujita T
    Jpn J Med; 1983 Apr; 22(2):117-21. PubMed ID: 6865104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.